Engineering biology firm Sherlock Biosciences amasses over $31 mln Series A
Sherlock Biosciences, an engineering biology company, has raised over $31 million in Series A funding. The investors included Northpond Ventures, Baidu Ventures and the Open Philanthropy Project.
23 April 2019•1 min read
